Mark McDonald
Child & Adolescent Psychiatry · Los Angeles, CANPI 1114116506
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $22,850 of the $30,965 with a category attached, or 73.8%. AbbVie accounts for 89.5% of it on its own, with 11 other manufacturers making up the rest. Reporting peaked in 2021 at $12,837 and has fallen 87.7% since, to $1,576 in 2025. Among child & adolescent psychiatry clinicians in CA with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 240 payments — averaging $129.02 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$28K
- Sunovion Pharmaceuticals Inc.$802
- Johnson & Johnson$750
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$699
- Alkermes, Inc.$564
- Corium, LLC$165
- plus $265 from 6 others
What the payments were for
- Speaking & faculty fees$22,85074%
- Travel & lodging$4171%
- Food & beverage$7,69825%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie(2 entities) | 157 | $27,720 |
| Sunovion Pharmaceuticals Inc. | 20 | $802 |
| Johnson & Johnson | 11 | $750 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 26 | $699 |
| Alkermes, Inc. | 11 | $564 |
| Corium, LLC | 7 | $165 |
| Acadia Pharmaceuticals Inc | 2 | $125 |
| Neos Therapeutics, LP | 2 | $39 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Neurocrine Biosciences, Inc. | 1 | $29 |
| Sumitomo Pharma America, Inc. | 1 | $22 |
| Otsuka America Pharmaceutical, Inc. | 1 | $19 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$30,965 in reported general payments places this provider in the 95th percentile of 434 child & adolescent psychiatry providers in California.
See all child & adolescent psychiatry providers in California →
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 11 | $704 |
| Doxepin Hcl | 14 | $193 |
| Clonazepam | 21 | $86 |
| Trazodone Hcl | 13 | $83 |
Paid to pharmacies, not to this prescriber.
Other child & adolescent psychiatry in Los Angeles
- Syed NaqviLos Angeles$69K
- Rubina NajeebLos Angeles$2K
- Kevin CoxOjai$2.9M
- Sukhjit BrarFresno$283K
- Manpreet SinghSacramento$104K
- Ihab SolimanCorona del Mar$93K
- Ellen HeynemanSan Diego$62K
- James HartmanDanville$21K
- Mohsin KhaliqueSan Ramon$20K
- Mansoor ZuberiWalnut Creek$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.